Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Meropenem Injection Market Growth 2022-2028

  • LP 4822515
  • 122 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Meropenem Injection will have significant change from previous year. According to our (LP Information) latest study, the global Meropenem Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Meropenem Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Meropenem Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Meropenem Injection market, reaching US$ million by the year 2028. As for the Europe Meropenem Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Meropenem Injection players cover Pfizer, AuroMedics, Sandoz, and Amneal Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

0.25g/vial

0.5g/vial

1g/vial

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

AuroMedics

Sandoz

Amneal Pharmaceuticals

Sumitomo Dainippon Pharma

Fresenius Kabi

Mylan

Sagent Pharmaceuticals

Bionova Scientific

Macleods Pharmaceuticals

Johnlee Pharmaceuticals

Xinya Pharm

PKU HealthCare

United Laboratories

CSPC Group

Zhejiang Hisun Pharmaceutical

Luoxin Pharmaceutical

Hainan Haiyao Co., Ltd.

Shenzhen Haibin Pharmaceutical

Chongqin Shenghuaxi

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Meropenem Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Meropenem Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Meropenem Injection by Country/Region, 2017, 2022 & 2028

2.2 Meropenem Injection Segment by Type

2.2.1 0.25g/vial

2.2.2 0.5g/vial

2.2.3 1g/vial

2.3 Meropenem Injection Sales by Type

2.3.1 Global Meropenem Injection Sales Market Share by Type (2017-2022)

2.3.2 Global Meropenem Injection Revenue and Market Share by Type (2017-2022)

2.3.3 Global Meropenem Injection Sale Price by Type (2017-2022)

2.4 Meropenem Injection Segment by Application

2.4.1 Hospital

2.4.2 Clinics

2.4.3 Others

2.5 Meropenem Injection Sales by Application

2.5.1 Global Meropenem Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Meropenem Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Meropenem Injection Sale Price by Application (2017-2022)

3 Global Meropenem Injection by Company

3.1 Global Meropenem Injection Breakdown Data by Company

3.1.1 Global Meropenem Injection Annual Sales by Company (2020-2022)

3.1.2 Global Meropenem Injection Sales Market Share by Company (2020-2022)

3.2 Global Meropenem Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Meropenem Injection Revenue by Company (2020-2022)

3.2.2 Global Meropenem Injection Revenue Market Share by Company (2020-2022)

3.3 Global Meropenem Injection Sale Price by Company

3.4 Key Manufacturers Meropenem Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Meropenem Injection Product Location Distribution

3.4.2 Players Meropenem Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Meropenem Injection by Geographic Region

4.1 World Historic Meropenem Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Meropenem Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Meropenem Injection Annual Revenue by Geographic Region

4.2 World Historic Meropenem Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Meropenem Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Meropenem Injection Annual Revenue by Country/Region

4.3 Americas Meropenem Injection Sales Growth

4.4 APAC Meropenem Injection Sales Growth

4.5 Europe Meropenem Injection Sales Growth

4.6 Middle East & Africa Meropenem Injection Sales Growth

5 Americas

5.1 Americas Meropenem Injection Sales by Country

5.1.1 Americas Meropenem Injection Sales by Country (2017-2022)

5.1.2 Americas Meropenem Injection Revenue by Country (2017-2022)

5.2 Americas Meropenem Injection Sales by Type

5.3 Americas Meropenem Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Meropenem Injection Sales by Region

6.1.1 APAC Meropenem Injection Sales by Region (2017-2022)

6.1.2 APAC Meropenem Injection Revenue by Region (2017-2022)

6.2 APAC Meropenem Injection Sales by Type

6.3 APAC Meropenem Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Meropenem Injection by Country

7.1.1 Europe Meropenem Injection Sales by Country (2017-2022)

7.1.2 Europe Meropenem Injection Revenue by Country (2017-2022)

7.2 Europe Meropenem Injection Sales by Type

7.3 Europe Meropenem Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Meropenem Injection by Country

8.1.1 Middle East & Africa Meropenem Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Meropenem Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Meropenem Injection Sales by Type

8.3 Middle East & Africa Meropenem Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Meropenem Injection

10.3 Manufacturing Process Analysis of Meropenem Injection

10.4 Industry Chain Structure of Meropenem Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Meropenem Injection Distributors

11.3 Meropenem Injection Customer

12 World Forecast Review for Meropenem Injection by Geographic Region

12.1 Global Meropenem Injection Market Size Forecast by Region

12.1.1 Global Meropenem Injection Forecast by Region (2023-2028)

12.1.2 Global Meropenem Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Meropenem Injection Forecast by Type

12.7 Global Meropenem Injection Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Meropenem Injection Product Offered

13.1.3 Pfizer Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 AuroMedics

13.2.1 AuroMedics Company Information

13.2.2 AuroMedics Meropenem Injection Product Offered

13.2.3 AuroMedics Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AuroMedics Main Business Overview

13.2.5 AuroMedics Latest Developments

13.3 Sandoz

13.3.1 Sandoz Company Information

13.3.2 Sandoz Meropenem Injection Product Offered

13.3.3 Sandoz Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sandoz Main Business Overview

13.3.5 Sandoz Latest Developments

13.4 Amneal Pharmaceuticals

13.4.1 Amneal Pharmaceuticals Company Information

13.4.2 Amneal Pharmaceuticals Meropenem Injection Product Offered

13.4.3 Amneal Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amneal Pharmaceuticals Main Business Overview

13.4.5 Amneal Pharmaceuticals Latest Developments

13.5 Sumitomo Dainippon Pharma

13.5.1 Sumitomo Dainippon Pharma Company Information

13.5.2 Sumitomo Dainippon Pharma Meropenem Injection Product Offered

13.5.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sumitomo Dainippon Pharma Main Business Overview

13.5.5 Sumitomo Dainippon Pharma Latest Developments

13.6 Fresenius Kabi

13.6.1 Fresenius Kabi Company Information

13.6.2 Fresenius Kabi Meropenem Injection Product Offered

13.6.3 Fresenius Kabi Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fresenius Kabi Main Business Overview

13.6.5 Fresenius Kabi Latest Developments

13.7 Mylan

13.7.1 Mylan Company Information

13.7.2 Mylan Meropenem Injection Product Offered

13.7.3 Mylan Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mylan Main Business Overview

13.7.5 Mylan Latest Developments

13.8 Sagent Pharmaceuticals

13.8.1 Sagent Pharmaceuticals Company Information

13.8.2 Sagent Pharmaceuticals Meropenem Injection Product Offered

13.8.3 Sagent Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sagent Pharmaceuticals Main Business Overview

13.8.5 Sagent Pharmaceuticals Latest Developments

13.9 Bionova Scientific

13.9.1 Bionova Scientific Company Information

13.9.2 Bionova Scientific Meropenem Injection Product Offered

13.9.3 Bionova Scientific Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bionova Scientific Main Business Overview

13.9.5 Bionova Scientific Latest Developments

13.10 Macleods Pharmaceuticals

13.10.1 Macleods Pharmaceuticals Company Information

13.10.2 Macleods Pharmaceuticals Meropenem Injection Product Offered

13.10.3 Macleods Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Macleods Pharmaceuticals Main Business Overview

13.10.5 Macleods Pharmaceuticals Latest Developments

13.11 Johnlee Pharmaceuticals

13.11.1 Johnlee Pharmaceuticals Company Information

13.11.2 Johnlee Pharmaceuticals Meropenem Injection Product Offered

13.11.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Johnlee Pharmaceuticals Main Business Overview

13.11.5 Johnlee Pharmaceuticals Latest Developments

13.12 Xinya Pharm

13.12.1 Xinya Pharm Company Information

13.12.2 Xinya Pharm Meropenem Injection Product Offered

13.12.3 Xinya Pharm Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Xinya Pharm Main Business Overview

13.12.5 Xinya Pharm Latest Developments

13.13 PKU HealthCare

13.13.1 PKU HealthCare Company Information

13.13.2 PKU HealthCare Meropenem Injection Product Offered

13.13.3 PKU HealthCare Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 PKU HealthCare Main Business Overview

13.13.5 PKU HealthCare Latest Developments

13.14 United Laboratories

13.14.1 United Laboratories Company Information

13.14.2 United Laboratories Meropenem Injection Product Offered

13.14.3 United Laboratories Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 United Laboratories Main Business Overview

13.14.5 United Laboratories Latest Developments

13.15 CSPC Group

13.15.1 CSPC Group Company Information

13.15.2 CSPC Group Meropenem Injection Product Offered

13.15.3 CSPC Group Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 CSPC Group Main Business Overview

13.15.5 CSPC Group Latest Developments

13.16 Zhejiang Hisun Pharmaceutical

13.16.1 Zhejiang Hisun Pharmaceutical Company Information

13.16.2 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Offered

13.16.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Zhejiang Hisun Pharmaceutical Main Business Overview

13.16.5 Zhejiang Hisun Pharmaceutical Latest Developments

13.17 Luoxin Pharmaceutical

13.17.1 Luoxin Pharmaceutical Company Information

13.17.2 Luoxin Pharmaceutical Meropenem Injection Product Offered

13.17.3 Luoxin Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Luoxin Pharmaceutical Main Business Overview

13.17.5 Luoxin Pharmaceutical Latest Developments

13.18 Hainan Haiyao Co., Ltd.

13.18.1 Hainan Haiyao Co., Ltd. Company Information

13.18.2 Hainan Haiyao Co., Ltd. Meropenem Injection Product Offered

13.18.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Hainan Haiyao Co., Ltd. Main Business Overview

13.18.5 Hainan Haiyao Co., Ltd. Latest Developments

13.19 Shenzhen Haibin Pharmaceutical

13.19.1 Shenzhen Haibin Pharmaceutical Company Information

13.19.2 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Offered

13.19.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Shenzhen Haibin Pharmaceutical Main Business Overview

13.19.5 Shenzhen Haibin Pharmaceutical Latest Developments

13.20 Chongqin Shenghuaxi

13.20.1 Chongqin Shenghuaxi Company Information

13.20.2 Chongqin Shenghuaxi Meropenem Injection Product Offered

13.20.3 Chongqin Shenghuaxi Meropenem Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Chongqin Shenghuaxi Main Business Overview

13.20.5 Chongqin Shenghuaxi Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Meropenem Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Meropenem Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 0.25g/vial

Table 4. Major Players of 0.5g/vial

Table 5. Major Players of 1g/vial

Table 6. Global Meropenem Injection Sales by Type (2017-2022) & (K Units)

Table 7. Global Meropenem Injection Sales Market Share by Type (2017-2022)

Table 8. Global Meropenem Injection Revenue by Type (2017-2022) & ($ million)

Table 9. Global Meropenem Injection Revenue Market Share by Type (2017-2022)

Table 10. Global Meropenem Injection Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Meropenem Injection Sales by Application (2017-2022) & (K Units)

Table 12. Global Meropenem Injection Sales Market Share by Application (2017-2022)

Table 13. Global Meropenem Injection Revenue by Application (2017-2022)

Table 14. Global Meropenem Injection Revenue Market Share by Application (2017-2022)

Table 15. Global Meropenem Injection Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Meropenem Injection Sales by Company (2020-2022) & (K Units)

Table 17. Global Meropenem Injection Sales Market Share by Company (2020-2022)

Table 18. Global Meropenem Injection Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Meropenem Injection Revenue Market Share by Company (2020-2022)

Table 20. Global Meropenem Injection Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Meropenem Injection Producing Area Distribution and Sales Area

Table 22. Players Meropenem Injection Products Offered

Table 23. Meropenem Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Meropenem Injection Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Meropenem Injection Sales Market Share Geographic Region (2017-2022)

Table 28. Global Meropenem Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Meropenem Injection Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Meropenem Injection Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Meropenem Injection Sales Market Share by Country/Region (2017-2022)

Table 32. Global Meropenem Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Meropenem Injection Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Meropenem Injection Sales by Country (2017-2022) & (K Units)

Table 35. Americas Meropenem Injection Sales Market Share by Country (2017-2022)

Table 36. Americas Meropenem Injection Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Meropenem Injection Revenue Market Share by Country (2017-2022)

Table 38. Americas Meropenem Injection Sales by Type (2017-2022) & (K Units)

Table 39. Americas Meropenem Injection Sales Market Share by Type (2017-2022)

Table 40. Americas Meropenem Injection Sales by Application (2017-2022) & (K Units)

Table 41. Americas Meropenem Injection Sales Market Share by Application (2017-2022)

Table 42. APAC Meropenem Injection Sales by Region (2017-2022) & (K Units)

Table 43. APAC Meropenem Injection Sales Market Share by Region (2017-2022)

Table 44. APAC Meropenem Injection Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Meropenem Injection Revenue Market Share by Region (2017-2022)

Table 46. APAC Meropenem Injection Sales by Type (2017-2022) & (K Units)

Table 47. APAC Meropenem Injection Sales Market Share by Type (2017-2022)

Table 48. APAC Meropenem Injection Sales by Application (2017-2022) & (K Units)

Table 49. APAC Meropenem Injection Sales Market Share by Application (2017-2022)

Table 50. Europe Meropenem Injection Sales by Country (2017-2022) & (K Units)

Table 51. Europe Meropenem Injection Sales Market Share by Country (2017-2022)

Table 52. Europe Meropenem Injection Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Meropenem Injection Revenue Market Share by Country (2017-2022)

Table 54. Europe Meropenem Injection Sales by Type (2017-2022) & (K Units)

Table 55. Europe Meropenem Injection Sales Market Share by Type (2017-2022)

Table 56. Europe Meropenem Injection Sales by Application (2017-2022) & (K Units)

Table 57. Europe Meropenem Injection Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Meropenem Injection Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Meropenem Injection Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Meropenem Injection Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Meropenem Injection Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Meropenem Injection Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Meropenem Injection Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Meropenem Injection Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Meropenem Injection Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Meropenem Injection

Table 67. Key Market Challenges & Risks of Meropenem Injection

Table 68. Key Industry Trends of Meropenem Injection

Table 69. Meropenem Injection Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Meropenem Injection Distributors List

Table 72. Meropenem Injection Customer List

Table 73. Global Meropenem Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Meropenem Injection Sales Market Forecast by Region

Table 75. Global Meropenem Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Meropenem Injection Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Meropenem Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Meropenem Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Meropenem Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Meropenem Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Meropenem Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Meropenem Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Meropenem Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Meropenem Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Meropenem Injection Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Meropenem Injection Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Meropenem Injection Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Meropenem Injection Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Meropenem Injection Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Meropenem Injection Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Meropenem Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Meropenem Injection Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Meropenem Injection Product Offered

Table 95. Pfizer Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. AuroMedics Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 99. AuroMedics Meropenem Injection Product Offered

Table 100. AuroMedics Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. AuroMedics Main Business

Table 102. AuroMedics Latest Developments

Table 103. Sandoz Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 104. Sandoz Meropenem Injection Product Offered

Table 105. Sandoz Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Sandoz Main Business

Table 107. Sandoz Latest Developments

Table 108. Amneal Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 109. Amneal Pharmaceuticals Meropenem Injection Product Offered

Table 110. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Amneal Pharmaceuticals Main Business

Table 112. Amneal Pharmaceuticals Latest Developments

Table 113. Sumitomo Dainippon Pharma Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 114. Sumitomo Dainippon Pharma Meropenem Injection Product Offered

Table 115. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Sumitomo Dainippon Pharma Main Business

Table 117. Sumitomo Dainippon Pharma Latest Developments

Table 118. Fresenius Kabi Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 119. Fresenius Kabi Meropenem Injection Product Offered

Table 120. Fresenius Kabi Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Fresenius Kabi Main Business

Table 122. Fresenius Kabi Latest Developments

Table 123. Mylan Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 124. Mylan Meropenem Injection Product Offered

Table 125. Mylan Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Mylan Main Business

Table 127. Mylan Latest Developments

Table 128. Sagent Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 129. Sagent Pharmaceuticals Meropenem Injection Product Offered

Table 130. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Sagent Pharmaceuticals Main Business

Table 132. Sagent Pharmaceuticals Latest Developments

Table 133. Bionova Scientific Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 134. Bionova Scientific Meropenem Injection Product Offered

Table 135. Bionova Scientific Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Bionova Scientific Main Business

Table 137. Bionova Scientific Latest Developments

Table 138. Macleods Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 139. Macleods Pharmaceuticals Meropenem Injection Product Offered

Table 140. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Macleods Pharmaceuticals Main Business

Table 142. Macleods Pharmaceuticals Latest Developments

Table 143. Johnlee Pharmaceuticals Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 144. Johnlee Pharmaceuticals Meropenem Injection Product Offered

Table 145. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Johnlee Pharmaceuticals Main Business

Table 147. Johnlee Pharmaceuticals Latest Developments

Table 148. Xinya Pharm Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 149. Xinya Pharm Meropenem Injection Product Offered

Table 150. Xinya Pharm Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Xinya Pharm Main Business

Table 152. Xinya Pharm Latest Developments

Table 153. PKU HealthCare Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 154. PKU HealthCare Meropenem Injection Product Offered

Table 155. PKU HealthCare Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. PKU HealthCare Main Business

Table 157. PKU HealthCare Latest Developments

Table 158. United Laboratories Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 159. United Laboratories Meropenem Injection Product Offered

Table 160. United Laboratories Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. United Laboratories Main Business

Table 162. United Laboratories Latest Developments

Table 163. CSPC Group Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 164. CSPC Group Meropenem Injection Product Offered

Table 165. CSPC Group Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. CSPC Group Main Business

Table 167. CSPC Group Latest Developments

Table 168. Zhejiang Hisun Pharmaceutical Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 169. Zhejiang Hisun Pharmaceutical Meropenem Injection Product Offered

Table 170. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Zhejiang Hisun Pharmaceutical Main Business

Table 172. Zhejiang Hisun Pharmaceutical Latest Developments

Table 173. Luoxin Pharmaceutical Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 174. Luoxin Pharmaceutical Meropenem Injection Product Offered

Table 175. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. Luoxin Pharmaceutical Main Business

Table 177. Luoxin Pharmaceutical Latest Developments

Table 178. Hainan Haiyao Co., Ltd. Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 179. Hainan Haiyao Co., Ltd. Meropenem Injection Product Offered

Table 180. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 181. Hainan Haiyao Co., Ltd. Main Business

Table 182. Hainan Haiyao Co., Ltd. Latest Developments

Table 183. Shenzhen Haibin Pharmaceutical Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 184. Shenzhen Haibin Pharmaceutical Meropenem Injection Product Offered

Table 185. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 186. Shenzhen Haibin Pharmaceutical Main Business

Table 187. Shenzhen Haibin Pharmaceutical Latest Developments

Table 188. Chongqin Shenghuaxi Basic Information, Meropenem Injection Manufacturing Base, Sales Area and Its Competitors

Table 189. Chongqin Shenghuaxi Meropenem Injection Product Offered

Table 190. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 191. Chongqin Shenghuaxi Main Business

Table 192. Chongqin Shenghuaxi Latest Developments

List of Figures

Figure 1. Picture of Meropenem Injection

Figure 2. Meropenem Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Meropenem Injection Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Meropenem Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Meropenem Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 0.25g/vial

Figure 10. Product Picture of 0.5g/vial

Figure 11. Product Picture of 1g/vial

Figure 12. Global Meropenem Injection Sales Market Share by Type in 2021

Figure 13. Global Meropenem Injection Revenue Market Share by Type (2017-2022)

Figure 14. Meropenem Injection Consumed in Hospital

Figure 15. Global Meropenem Injection Market: Hospital (2017-2022) & (K Units)

Figure 16. Meropenem Injection Consumed in Clinics

Figure 17. Global Meropenem Injection Market: Clinics (2017-2022) & (K Units)

Figure 18. Meropenem Injection Consumed in Others

Figure 19. Global Meropenem Injection Market: Others (2017-2022) & (K Units)

Figure 20. Global Meropenem Injection Sales Market Share by Application (2017-2022)

Figure 21. Global Meropenem Injection Revenue Market Share by Application in 2021

Figure 22. Meropenem Injection Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Meropenem Injection Revenue Market Share by Company in 2021

Figure 24. Global Meropenem Injection Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Meropenem Injection Revenue Market Share by Geographic Region in 2021

Figure 26. Global Meropenem Injection Sales Market Share by Region (2017-2022)

Figure 27. Global Meropenem Injection Revenue Market Share by Country/Region in 2021

Figure 28. Americas Meropenem Injection Sales 2017-2022 (K Units)

Figure 29. Americas Meropenem Injection Revenue 2017-2022 ($ Millions)

Figure 30. APAC Meropenem Injection Sales 2017-2022 (K Units)

Figure 31. APAC Meropenem Injection Revenue 2017-2022 ($ Millions)

Figure 32. Europe Meropenem Injection Sales 2017-2022 (K Units)

Figure 33. Europe Meropenem Injection Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Meropenem Injection Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Meropenem Injection Revenue 2017-2022 ($ Millions)

Figure 36. Americas Meropenem Injection Sales Market Share by Country in 2021

Figure 37. Americas Meropenem Injection Revenue Market Share by Country in 2021

Figure 38. United States Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Meropenem Injection Sales Market Share by Region in 2021

Figure 43. APAC Meropenem Injection Revenue Market Share by Regions in 2021

Figure 44. China Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Meropenem Injection Sales Market Share by Country in 2021

Figure 51. Europe Meropenem Injection Revenue Market Share by Country in 2021

Figure 52. Germany Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Meropenem Injection Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Meropenem Injection Revenue Market Share by Country in 2021

Figure 59. Egypt Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Meropenem Injection Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Meropenem Injection in 2021

Figure 65. Manufacturing Process Analysis of Meropenem Injection

Figure 66. Industry Chain Structure of Meropenem Injection

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390